Investor Alert

Company Close Updates Archives | Email alerts

Jan. 26, 2021, 4:55 p.m. EST

AstraZeneca PLC ADR outperforms competitors on strong trading day

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

The AstraZeneca PLC ADR AZN inched 0.80% higher to $54.44 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.07% to 13,626.06 and Dow Jones Industrial Average DJIA falling 0.07% to 30,937.04. This was the ADR's fourth consecutive day of gains. AstraZeneca PLC ADR closed $10.50 short of its 52-week high ($64.94), which the company achieved on July 20th.

The ADR outperformed some of its competitors Tuesday, as AbbVie Inc. ABBV fell 1.54% to $108.80, Amgen Inc. AMGN rose 0.58% to $258.60, and Gilead Sciences Inc. GILD fell 2.14% to $66.70. Trading volume (11.6 M) remained 156,018 below its 50-day average volume of 11.8 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.